Show simple item record

dc.contributor.authorJoseph, N
dc.contributor.authorChoudhury, Ananya
dc.date.accessioned2019-06-25T09:32:58Z
dc.date.available2019-06-25T09:32:58Z
dc.date.issued2019en
dc.identifier.citationJoseph N, Choudhury A. SABR versus conventional fractionation regimens in NSCLC. Lancet Oncol. 2019 May;20(5):e231.en
dc.identifier.pmid31044708en
dc.identifier.doi10.1016/S1470-2045(19)30180-9en
dc.identifier.urihttp://hdl.handle.net/10541/621911
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/S1470-2045(19)30180-9en
dc.titleSABR versus conventional fractionation regimens in NSCLCen
dc.typeArticleen
dc.contributor.departmentMinistry of Health, Colombo 01000, Sri Lanka.en
dc.identifier.journalThe Lancet Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record